(Baylor College of Medicine) A new-method analyzes the combination of tumor genetic material (genomics) with deep protein and phosphoprotein characterization (proteomics) using a single-needle core biopsy from a patient’s tumor, providing more detailed information about the cancer than conventional approaches.

Original source: https://www.eurekalert.org/pub_releases/2020-01/bcom-mmh012720.php